Investigating how lymphatic clearance affects brain tuberculosis
The role of lymphatic clearance in brain TB
This study is looking at how the lymphatic vessels in the brain are affected by brain tuberculosis, which can cause serious inflammation and damage, and it hopes to find new ways to help treat this condition and improve brain health for those who have it.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-11087570 on NIH RePORTER |
What this research studies
This research explores the role of lymphatic vessels in the brain and how they relate to brain tuberculosis, a severe form of TB that can cause significant inflammation and damage. The study aims to understand how these lymphatic vessels, which help manage fluid and immune responses, are affected by brain TB. By examining the formation and function of these vessels, the research seeks to uncover their impact on disease progression and cognitive decline. Patients may benefit from insights that could lead to new treatment strategies for brain TB and related conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with brain tuberculosis or those experiencing related neurological symptoms.
Not a fit: Patients with non-neurological forms of tuberculosis or those without any signs of brain involvement may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options for patients suffering from brain tuberculosis and potentially other neurological conditions.
How similar studies have performed: While the specific focus on lymphatic clearance in brain tuberculosis is novel, previous studies have shown success in understanding lymphatic functions in other neurological diseases.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Sandor, Matyas — University of Wisconsin-Madison
- Study coordinator: Sandor, Matyas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.